LCGC
CVS icon

Legacy Capital Group California’s CVS Health CVS Stock Holding History

Legacy Capital Group California’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.05M Sell
19,811
-449
-2% -$40.1K 0.62% 25
2026
Q1 		$1.46M Buy
20,260
+5,510
+37% +$424K 0.55% 32
2025
Q4 		$1.17M Sell
14,750
-59
-0.4% -$4.65K 0.28% 87
2025
Q3 		$1.12M Buy
14,809
+92
+0.6% +$6.3K 0.28% 89
2025
Q2 		$1.02M Sell
14,717
-384
-3% -$25.2K 0.28% 93
2025
Q1 		$1.02M Sell
15,101
-133
-0.9% -$7.96K 0.36% 54
2024
Q4 		$684K Sell
15,234
-88
-0.6% -$4.94K 0.21% 134
2024
Q3 		$963K Sell
15,322
-386
-2% -$22.5K 0.32% 76
2024
Q2 		$928K Buy
15,708
+5,165
+49% +$323K 0.33% 80
2024
Q1 		$841K Sell
10,543
-222
-2% -$17K 0.31% 100
2023
Q4 		$850K Buy
10,765
+72
+0.7% +$5.12K 0.33% 83
2023
Q3 		$747K Sell
10,693
-9,538
-47% -$676K 0.32% 89
2023
Q2 		$1.4M Buy
20,231
+2,960
+17% +$211K 0.58% 28
2023
Q1 		$1.28M Buy
+17,271
New +$1.45M 0.63% 42

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Legacy Capital Group California's CVS Position: Q2 2026 in Review

Legacy Capital Group California reduced its CVS Health (CVS) stake by 2.2% in Q2 2026, selling an estimated $40.1K and leaving 19,811 shares worth $2.05M. The position accounts for 0.62% of the portfolio, ranked #25.

Legacy Capital Group California first reported a position in CVS in Q1 2023 and has held it in 14 quarters since. 2,067 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Legacy Capital Group California held 19,811 shares of CVS Health worth $2.05M as of Q2 2026.
  • Legacy Capital Group California sold 449 CVS Health shares in Q2 2026, an estimated $40.1K.
  • CVS Health made up 0.62% of Legacy Capital Group California's portfolio in Q2 2026, its #25 holding.
  • Legacy Capital Group California first reported a position in CVS Health in Q1 2023 and has held it in 14 quarters since.
  • 2,067 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Legacy Capital Group California's 13F filing for Q2 2026, filed 29 Jul 2026.